Raza headshotInvestigator: Dr. Azra Raza and Dr. Naomi Galili

Research Institution: Columbia University

Disease: Myelodysplastic Syndrome

Research Description: Myelodysplastic syndrome (MDS) is a group of bone marrow disorders where the bone marrow cannot produce enough healthy cells. This leads to low blood cell counts and a higher risk for developing acute myeloid leukemia. In the last couple of years, our understanding of the molecular genetic basis of MDS has increased exponentially. This research will look at a specific type called of MDS called RARS, which is found in 10-15% of all MDS patients. The research team will identify mutations unique to MDS‐RARS patients, and use new technologies, such as CRISPR CAs9 gene editing, to see if altering certain genes can increase cell survival. They expect that these results will provide insights into repurposed therapies that can be rapidly developed and used in the clinic.

CWR fuding role: Primary funder 

Start date: August 1, 2012

 

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please email susan@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Tuesday the 18th. Copyright 2018 Cures Within Reach.